Effect of overexpression of heparanase on proliferation of gallbladder cancer cells and PI3K/AKT signaling pathway

WEN Bo; LIU Zixiang; ZHANG Ziyan; CHEN Jiawei; WANG Zhenglin; ZHOU Shaobo

doi:10.7619/jcmp.20213823

Journal of Clinical Medicine in Practice > 2022 > 26(2): 56-61. > DOI: 10.7619/jcmp.20213823

WEN Bo, LIU Zixiang, ZHANG Ziyan, CHEN Jiawei, WANG Zhenglin, ZHOU Shaobo. Effect of overexpression of heparanase on proliferation of gallbladder cancer cells and PI3K/AKT signaling pathway[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 56-61. DOI: 10.7619/jcmp.20213823

Citation:

PDF (2597 KB)

Effect of overexpression of heparanase on proliferation of gallbladder cancer cells and PI3K/AKT signaling pathway

Department of General Surgery, the Second Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, 233000

More Information

Received Date: September 22, 2021
Available Online: March 01, 2022
Published Date: January 27, 2022

Graphical Abstract

Abstract

Abstract

Objective To explore the effect of overexpression of heparanase (HPSE) on the proliferation of gallbladder cancer cell line GBC-SD and the phosphatidylinositol 3-kinase/protein serine-threonine kinase (PI3K/AKT) signaling pathway.
Methods The HPSE eukaryotic expression vector was constructed, and then the gallbladder cancer cell line GBD-SD with transgenic overexpression of HPSE was obtained. The mRNA and protein expression of HPSE in GBC-SD and GBD-SD were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot. The proliferation of cells in each group was assessed by colony formation assay and MTT. The protein levels of PI3K/AKT signaling pathway related proteins (p-PI3K, PI3K, p-AKT and AKT) were analyzed by western blot.
Results The mRNA and protein levels of HPSE in GBD-SD after successful transfection were significantly increased (P < 0.01). Compared to GBC-SD with normal expression of HPSE, the optical density (OD) value and colony formation ability of GBD-SD cells with overexpression of heparanase were significantly increased (P < 0.05). The results of western blot showed that compared with GBC-SD cells, the expression levels of p-AKT, p-PI3K protein, p-AKT/AKT value and p-PI3K/PI3K value in GBD-SD cells with overexpression of HPSE were increased significantly (P < 0.01), but the expression levels of total AKT and total PI3K protein did not change obviously. After 2 days of treatment with specific inhibitor LY294002 for PI3K/AKT pathway, the proliferation ability and p-AKT/AKT value of GBC-SD cells were significantly decreased (P < 0.01).
Conclusion Overexpression of HPSE can promote the proliferation of GBC-SD cells, which may be related to the PI3K/AKT signaling pathway.
- gallbladder cancer,
- heparanase,
- cell proliferation,
- phosphatidylinositol 3-kinase,
- protein serine-threonine kinases,
- signaling pathway

FullText(HTML)

References (30)

References

[1]	滕世峰, 李新星, 张言言, 等. 胆囊癌组织中TROP2、PTEN和p-AKT的表达及其临床意义[J]. 肝胆胰外科杂志, 2017, 29(1): 46-50. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYW201701012.htm
[2]	MATSUSHITA S, ONISHI H, NAKANO K, et al. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer[J]. Cancer Sci, 2014, 105(3): 272-280. doi: 10.1111/cas.12354
[3]	ZONG H J, YIN B B, ZHOU H D, et al. Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition[J]. Mol Biol Rep, 2014, 41(7): 4507-4512. doi: 10.1007/s11033-014-3321-4
[4]	BARASH U, LAPIDOT M, ZOHAR Y, et al. Involvement of heparanase in the pathogenesis of mesothelioma: basic aspects and clinical applications[J]. J Natl Cancer Inst, 2018, 110(10): 1102-1114. doi: 10.1093/jnci/djy032
[5]	HERMANO E, GOLDBERG R, RUBINSTEIN A M, et al. Heparanase accelerates obesity-associated breast cancer progression[J]. Cancer Res, 2019, 79(20): 5342-5354. doi: 10.1158/0008-5472.CAN-18-4058
[6]	PURUSHOTHAMAN A, SANDERSON R D. Heparanase: a dynamic promoter of myeloma progression[J]. Adv Exp Med Biol, 2020, 1221: 331-349.
[7]	CASSINELLI G, LANZI C. Heparanase: a potential therapeutic target in sarcomas[J]. Adv Exp Med Biol, 2020, 1221: 405-431.
[8]	刘子祥, 周少波, 张子艳. 过表达乙酰肝素酶促进胆囊癌细胞系GBC-SD的增殖和迁移[J]. 基础医学与临床, 2020, 40(2): 198-202. doi: 10.3969/j.issn.1001-6325.2020.02.012
[9]	POLIVKA J Jr, JANKU F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway[J]. Pharmacol Ther, 2014, 142(2): 164-175. doi: 10.1016/j.pharmthera.2013.12.004
[10]	MILLER K D, GODING SAUER A, ORTIZ A P, et al. Cancer statistics for hispanics/latinos, 2018[J]. CA Cancer J Clin, 2018, 68(6): 425-445. doi: 10.3322/caac.21494
[11]	RIVARA S, MILAZZO F M, GIANNINI G. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases[J]. Future Med Chem, 2016, 8(6): 647-680. doi: 10.4155/fmc-2016-0012
[12]	GROULT H, COUSIN R, CHOT-PLASSOT C, et al. Λ-carrageenan oligosaccharides of distinct anti-heparanase and anticoagulant activities inhibit MDA-MB-231 breast cancer cell migration[J]. Mar Drugs, 2019, 17(3): E140. doi: 10.3390/md17030140
[13]	LIU L P, SHENG X P, SHUAI T K, et al. Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression[J]. World J Gastroenterol, 2021, 27(22): 3138-3141. doi: 10.3748/wjg.v27.i22.3138
[14]	TATSUMI Y, MIYAKE M, SHIMADA K, et al. Inhibition of heparanase expression results in suppression of invasion, migration and adhesion abilities of bladder cancer cells[J]. Int J Mol Sci, 2020, 21(11): E3789. doi: 10.3390/ijms21113789
[15]	BARASH U, SPYROU A, LIU P, et al. Heparanase promotes glioma progression via enhancing CD24 expression[J]. Int J Cancer, 2019, 145(6): 1596-1608. doi: 10.1002/ijc.32375
[16]	LI Y, LIU H, HUANG Y Y, et al. Suppression of endoplasmic Reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase[J]. Int J Mol Med, 2013, 31(5): 1234-1242. doi: 10.3892/ijmm.2013.1292
[17]	CHEN X P, LUO J S, TIAN Y, et al. Downregulation of heparanase expression results in suppression of invasion, migration, and adhesion abilities of hepatocellular carcinoma cells[J]. Biomed Res Int, 2015, 2015: 241983.
[18]	LIU C J, CHANG J, LEE P H, et al. Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence[J]. World J Gastroenterol, 2014, 20(32): 11384-11393. doi: 10.3748/wjg.v20.i32.11384
[19]	RITCHIE J P, RAMANI V C, REN Y S, et al. SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis[J]. Clin Cancer Res, 2011, 17(6): 1382-1393. doi: 10.1158/1078-0432.CCR-10-2476
[20]	ZHOU H, ROY S, COCHRAN E, et al. M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis[J]. PLoS One, 2011, 6(6): e21106. doi: 10.1371/journal.pone.0021106
[21]	JIN H, CUI M. Gene silencing of heparanase results in suppression of invasion and migration of gallbladder carcinoma cells[J]. Biosci Biotechnol Biochem, 2018, 82(7): 1116-1122. doi: 10.1080/09168451.2018.1456316
[22]	JIN D, YANG J P, HU J H, et al. MCP-1 stimulates spinal microglia via PI3K/Akt pathway in bone cancer pain[J]. Brain Res, 2015, 1599: 158-167. doi: 10.1016/j.brainres.2014.12.043
[23]	PETRULEA M S, PLANTINGA T S, SMIT J W, et al. PI3K/Akt/mTOR: a promising therapeutic target for non-medullary thyroid carcinoma[J]. Cancer Treat Rev, 2015, 41(8): 707-713. doi: 10.1016/j.ctrv.2015.06.005
[24]	WANG L, GAO C, YAO S K, et al. Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells[J]. Int J Mol Sci, 2013, 14(12): 23212-23230. doi: 10.3390/ijms141223212
[25]	EBRAHIMI S, HOSSEINI M, SHAHIDSALES S, et al. Targeting the Akt/PI3K signaling pathway as a potential therapeutic strategy for the treatment of pancreatic cancer[J]. Curr Med Chem, 2017, 24(13): 1321-1331.
[26]	BAHRAMI A, KHAZAEI M, SHAHIDSALES S, et al. The therapeutic potential of PI3K/Akt/mTOR inhibitors in breast cancer: rational and progress[J]. J Cell Biochem, 2018, 119(1): 213-222. doi: 10.1002/jcb.26136
[27]	DUAN Y, HAYBAECK J, YANG Z H. Therapeutic potential of PI3K/AKT/mTOR pathway in gastrointestinal stromal tumors: rationale and progress[J]. Cancers, 2020, 12(10): 2972. doi: 10.3390/cancers12102972
[28]	PRAMANIK K C, KUDUGUNTI S K, FOFARIA N M, et al. Caffeic acid phenethyl ester suppresses melanoma tumor growth by inhibiting PI3K/AKT/XIAP pathway[J]. Carcinogenesis, 2013, 34(9): 2061-2070. doi: 10.1093/carcin/bgt154
[29]	VLODAVSKY I, BAR-SHAVIT R, ISHAI-MICHAELI R, et al. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism[J]. Trends Biochem Sci, 1991, 16(7): 268-271.
[30]	CHEN X D, ZHAO H C, CHEN C Z, et al. The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation[J]. Oncol Lett, 2020, 19(1): 211-220.

[1]	HUANG Xiaoli, HUANG Xiaoyan, SONG Shuhui, ZHANG Ying. Correlations of prognostic nutritional index and modified Glasgow prognostic score with prognosis in patients with cervical cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(20): 12-17. DOI: 10.7619/jcmp.20233927
[2]	WANG Hao, LI Nanlin, CAO Hailing. Relationships of circulating tumor cells with prognosis and tumor status of triple-negative breast cancer[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 39-43. DOI: 10.7619/jcmp.20230815
[3]	GUO Yaqun, LI Yubo, TIAN Qian. Value of pre-treatment prognostic nutritional index and Controlling Nutritional Status score in predicting the prognosis of patients with ovarian cancer[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 23-27. DOI: 10.7619/jcmp.20230921
[4]	ZHAO Dan, GUO Liang, DENG Yunqun, YANG Mingli, LI Lijie. Comparison in effect of two nutritional status scores in evaluating prognosis of high-grade T1 stage bladder cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(2): 93-96, 100. DOI: 10.7619/jcmp.20200580
[5]	JIAO Junquan, QU Xinyan, DING Boyong. Effects of modified Bazhen Decoction and chemotherapy for patients with gastric cancer after radical operation[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 86-89. DOI: 10.7619/jcmp.201915023
[6]	LI Chun. The effect of therapeutic communication system on psychological status and prognosis for patients with spinal cord injury[J]. Journal of Clinical Medicine in Practice, 2017, (10): 51-53. DOI: 10.7619/jcmp.201710016
[7]	XU Change, ZENG Lijuan. Application of systematic respiratory nursing in lung cancer patients with surgery[J]. Journal of Clinical Medicine in Practice, 2017, (4): 82-84. DOI: 10.7619/jcmp.201704025
[8]	CHENG Xiaofei. Clinical research on TGOPC combined with docetaxel and platinum in treatment of patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2015, (19): 22-25. DOI: 10.7619/jcmp.201519007
[9]	GUO Hua, YAN Weihong, LI Yujuan, DING Hui. Study on molecular biological types of enterovirus infecting central nervous system[J]. Journal of Clinical Medicine in Practice, 2015, (9): 97-100. DOI: 10.7619/jcmp.201509028
[10]	SHANGGUAN Huaying, WEI Gang, FU Biyun. Repair effect of mouse nerve growth factor on the neurological function of hand-foot-and-mouth disease children with central lesion[J]. Journal of Clinical Medicine in Practice, 2014, (5): 6-9. DOI: 10.7619/jcmp.201405003

Cited By

Get Citation

PDF

XML

Article views (208) PDF downloads (6)

Turn off MathJax

Article Contents

Abstract

References

Effect of overexpression of heparanase on proliferation of gallbladder cancer cells and PI3K/AKT signaling pathway

Abstract

References

Related Articles

Catalog

Effect of overexpression of heparanase on proliferation of gallbladder cancer cells and PI3K/AKT signaling pathway

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content